Artificial IntelligenceCryptocurrencyMetaverseCybersecurityTech Forward

Data Sheet—Monday, October 10, 2016

October 10, 2016, 12:32 PM UTC

It’s plain to anyone who has visited the doctor that medicine’s relationship with information technology is tenuous at best. Merely hoping to have a timely email exchange with a physician can be an exercise in futility.

To a patient, the virtue of avoiding an office visit before refilling a routine prescription, for example, is obvious. Only an insane insurance system, which Kaiser sidesteps by owning its own hospitals, would think otherwise.

This frustrating conundrum is but a tiny example of the revolution happening because information technology finally is having a meaningful impact on health care and medicine. Controversy will follow. Over the weekend venture capitalist Vinod Khosla angrily swiped at competitor Marc Andreessen for misrepresenting Khosla’s perspective on the future role of doctors. Andreessen, interviewed on the impact artificial intelligence will have on medicine, said Khosla believes “doctors are going to go away.” Khosla promptly republished a lengthy treatise that suggests technology will enable doctors to refocus 80% of their time on the “human aspects” of practicing medicine.

It is a near certainty that tremendous good will come from the likes of Andreessen and Khosla bickering with each other—with each investing according to their respective theses.

As it happens, Fortune has a contribution to make to the discussion. On the first two days of November, in San Diego, we are hosting the inaugural Brainstorm HEALTH conference. As my pal and conference guiding light Clifton Leaf has written: “We’ll probe the potential of all this new medtech, challenge orthodoxy, poke a few sacred cows, and do a fair amount of big-sky dreaming about what’s possible—and what ought to be.”

This conference is an exciting extension of our Brainstorm franchise, and like our other conferences, attendance at Brainstorm HEALTH is by invitation only. But if your world overlaps with the program—view the preliminary agenda here—we welcome your application.

Have a healthy week.

Adam Lashinsky



Samsung's second Galaxy Note 7 recall isn't going well. The South Korean has halted production of the smartphone, again, after reports of fires in the replacement batch. U.S. carriers participating in the recall, including AT&T and T-Mobile, said they've directed staff not to issue new Galaxy 7 phones to owners seeking an exchange. Those customers will need to opt for a different smartphone model until Samsung resolves the safety concerns. (New York Times, Wall Street Journal)

Twitter takeover talks fizzle. The social media company cancelled a special meeting last Friday to discuss potential bids, reports Bloomberg. The move came after three high-profile potential suitors—Disney, Google, and—got cold feet. (Bloomberg, New York Times)

Oracle's $9.3 billion buyout of NetSuite is in jeopardy. The software giant is giving shareholders until Nov. 4 to tender their stock. This is the second, month-long extension. Oracle needs 20.4 million shares to seal the deal, but only about one-quarter of that amount has been tendered. NetSuite's biggest shareholder T. Rowe Price Group thinks Oracle's offer undervalues the company. (FortuneWall Street Journal)

Twilio files for secondary stock offering. The software company filed paperwork with the Securities and Exchange Commission to sell another batch of Class A shares worth $400 million. Most of them are owned by existing shareholders.  (VentureBeat)

This software could make flying less miserable. New York's JFK Airport is using a new predictive analytics system, called Beontra, to coordinate 32 airlines and more than 20 million annual flights in its newest terminal. Among other things, it uses data about schedule changes and passenger habits to help the TSA, airlines, and immigration officials make better staffing decisions. (Wired)


Jack Ma's latest business partner is Steven Spielberg. China's top tech titan is making a minority investment in the acclaimed director's production company, Amblin Partners (formerly known as DreamWorks Studios) through Alibaba Pictures. The underlying intention is to co-produce movies for both Chinese and global audiences. (Fortune)

Yahoo faces more anti-male discrimination claims. Aside from concerns over cybersecurity policy, Yahoo's buyer Verizon will inherit another thorny legal matter. A second former executive is suing the Internet company, accusing two female managers in the Yahoo media organization of a pattern of bias against men. (Ars Technica)


A guide to this week's Apple-Samsung ultimate legal showdown. On Tuesday, the country's top court will hear a long-running feud between [f500link ignore=true]Apple[/f500link] and Samsung over the design of the iPhone. The stakes are high: $400 million, an important intellectual property law issue—and a lot of pride for two corporate rivals and the consumers who love them. Apple won a separate $120 million last Friday that involved three software patents, including the "slide to unlock" feature.

The spat began in 2011 after Apple's late founder Steve Jobs declared "thermonuclear war" against the Android operating system that powers Samsung smartphones, and will likely end next year.

Here's a plain English guide to the case based on interviews with patent experts, lawyers, and sources close to Apple and Samsung.


Dreamforce Explores the Ridiculous, the Sublime, and the Somewhat Scary, by Barb Darrow

Slack's CEO Suggests Bots Are Overhyped, by Robert Hackett

An Apple a Day: A Time for Reflection, by Don Reisinger

Facebook's Events Feature Gets Its Own Standalone App, by Leena Rao


There's reason so many computer voice assistants sound like young women or British butlers. Science, stereotypes, and regional preferences are just three of the factors that play in the speech patterns used by a digital persona. Plus, why the voice given to the IBM Watson analytics software is an exception. (New York Times)

This edition of Data Sheet was curated by Heather Clancy.
Find past issues. Sign up for other Fortune newsletters.